Net margin is calculated as Net Income divided by its Revenue. Nemaura Medical's Net Income for the
three
months ended in Dec. 2023 was $-2.16 Mil. Nemaura Medical's Revenue for the
three
months ended in Dec. 2023 was $0.00 Mil. Therefore, Nemaura Medical's net margin for the quarter that ended in Dec. 2023 was 0.00%.
The historical rank and industry rank for Nemaura Medical's Net Margin % or its related term are showing as below:
NMRD's Net Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -1.11 * Ranked among companies with meaningful Net Margin % only.
Nemaura Medical Net Margin % Historical Data
The historical data trend for Nemaura Medical's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Nemaura Medical's Net Margin %
For the Medical Devices subindustry, Nemaura Medical's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nemaura Medical's Net Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nemaura Medical's Net Margin % distribution charts can be found below:
* The bar in red indicates where Nemaura Medical's Net Margin % falls into.
Nemaura Medical Net Margin % Calculation
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
Nemaura Medical's Net Margin for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nemaura Medical (OTCPK:NMRD) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Nemaura Medical Net Margin % Related Terms
Thank you for viewing the detailed overview of Nemaura Medical's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Nemaura Medical Inc is a medical technology company developing sugarBEAT as a non-invasive, affordable, and flexible Continuous Glucose Monitor (CGM) designed for people with diabetes and pre-diabetics to manage their glucose levels. Insulin users can adjunctively use sugarBEAT when calibrated with a finger-stick glucose reading. SugarBEAT consists of a daily disposable adhesive skin patch connected to a rechargeable transmitter with an app displaying glucose readings at five-minute intervals for periods up to 24 hours.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NMRD has been successfully added to your 